Caplin Point Laboratories Limited (CAPLIPOINT) Stock Statistics & Valuation Metrics

Caplin Point Laboratories Limited has a market cap or net worth of ₹192.72B. The enterprise value is ₹172.14B.

Caplin Point Laboratories Limited has 76,011,696 shares outstanding. The number of shares has decreased by -2.65% in one year.

Caplin Point Laboratories Limited’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 15.21%.

The current PE Ratio of Caplin Point Laboratories Limited is 30.1. Caplin Point Laboratories Limited’s PEG ratio is 0.91.

In the last 12 months, Caplin Point Laboratories Limited had revenue of 21.87B and earned 6.41B in profits. Earnings per share was 84.36.

In the last 12 months, operating cash flow was 2.54B and capital expenditures -938.80M, giving a free cash flow of 1.60B billion.

Caplin Point Laboratories Limited pays an annual dividend of ₹4, resulting in a dividend yield of 0.31%

Caplin Point Laboratories Limited upcoming earnings date is Aug 12, 2026, TBA (Confirmed).

Caplin Point Laboratories Limited as a current ratio of 6.70, with Debt / Equity ratio of 0.13%

In the past 12 months, Caplin Point Laboratories Limited has paid 1.53B in taxes.

Caplin Point Laboratories Limited EV to EBITDA ratio is 12.35, with an EV/FCF ratio of 32.15.

Caplin Point Laboratories Limited has ₹10.07B in cash and marketable securities with ₹46.10M in debt, giving a net cash position of ₹10.02B billion.

Gross margin is 51.00%, with operating margin of 31.46%, and net profit margin of 29.32%.

The average price target for Caplin Point Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―